Loren Data's SAM Daily™

FBO DAILY - FEDBIZOPPS ISSUE OF APRIL 05, 2017 FBO #5612
DOCUMENT

65 -- UVC Sterilizer Questions & Answers Extension Quotes Due 04/10/2017 @15:00 EST - Attachment

Notice Date

4/3/2017
 

Notice Type

Attachment
 

NAICS

334510 — Electromedical and Electrotherapeutic Apparatus Manufacturing
 

Contracting Office

Department of Veterans Affairs;Network Contracting Office (NCO) 10;6150 Oak Tree Blvd., Suite 300;Independence OH 44131
 

ZIP Code

44131
 

Solicitation Number

VA25017Q0237
 

Response Due

4/10/2017
 

Archive Date

6/9/2017
 

Point of Contact

Department of Veterans Affairs
 

E-Mail Address

opher
 

Small Business Set-Aside

Total Small Business
 

Description

The following questions were submitted by a potential offeror. 1- The government states, This system will allow medical staff to disinfect patient rooms and specific surfaces to increase C. difficile infection (CDI) prevention at Louis Stokes Cleveland VA Medical Center.   What will the government use to evaluate this objective?   An evidence-based decision criteria would suggest c-diff outcome studies published in peer-reviewed journals showing reductions in unit and/or facility wide c-diff infection rates. What is the C diff rate reduction that will be used to evaluate this objective? UVC sterilization is part of a comprehensive Infection Prevention and Control program and LSCVAMC will evaluate -all bids according to the specifications within solicitation # VA250-17-Q-0237. 2- The government identifies a requirement for 30 UVC disinfection systems.   What is the requirement for rooms to be disinfected per day?   Some portable touch-free UVC disinfection systems have been shown to deliver a sporicidal room disinfection in as many as 60 rooms/day.   If a lower number of systems meets the rooms to be disinfected per day, is this acceptable? In other words, it is requested that the agency define its needs based on the room disinfection requirements.   Those requirements may be met by a different number of systems by different offerors.     LSCVAMC has a comprehensive Infection Prevention and Control program that has evaluated how UVC may enhance the efficacy for cleaning patient rooms.   The room disinfection requirements for UVC sterilization are specified in the solicitation # VA250-17-Q-0237.   These requirements include; The UVC disinfection system shall be portable (e.g., easily moved and carried around from room to room and floor to floor by EMS employee) The UVC disinfection system shall be Compact (e.g., adjustable arms shall retract and fold for easy storage when not in use) The UVC disinfection system shall be adjustable (e.g., UVC lamps on extendable and flexible arms to treat hard to reach surfaces) including; tilting and directing the UVC toward hard to reach surfaces The UVC disinfection system shall have multiple UVC lamps (minimum of 3) on adjustable arms that can be directed at multiple targets The UVC disinfection system shall have the ability to target (i.e., treat) surfaces between 1 7 feet above the floor 3- If a UVC disinfection technology has been shown to reduce c diff infection rates (as evidenced in published, peer reviewed outcome studies) and does not employ multiple, adjustable lamps will it still be an acceptable technology?   The agency s requirement is a system that is versatile and able to treat hard to reach surfaces.   Adjustable lamps may be one way to meet that requirement but it is not the only way.   Some UVC technologies utilize multiple positions in a room to reduce shadowing.   Additionally, in some of these technologies the flashlamp moves during the treatment cycle to change the angle of attack further increasing the disinfection area. UVC sterilization is part of a comprehensive Infection Prevention and Control program and LSCVAMC will evaluate all bids according to the specifications within solicitation # VA250-17-Q-0237. 4- There are technologies that can meet the VA s stated disinfection objectives that do not have adjustable lamps.   If a technology meets the requirement to be versatile and treat hard to reach surfaces, must it have multiple, adjustable lamps?   Indeed, no mercury UVC system has been shown to reduce c-diff infection rates (as evidenced in peer-reviewed published outcome studies).   This includes TRU-D (28 mercury lamps) and MOONBEAM-3 (3 mercury lamps).   The pulsed xenon UV germ-zapping robot is the only UV disinfection technology whose users have published multiple studies showing reductions in c-diff rates. LSCVAMC will evaluate your bid according to the specifications within solicitation # VA250-17-Q-0237. 5- Continuous mercury UVC devices (253.7nm) have not been proven to reduce c-diff infection rates.   In fact, the recently published BETR-D study which studied continuous mercury UVC devices showed no statistical reductions in c-diff rates.   Furthermore, a MOONBEAM-3 study showing any statistically significant reductions in c-diff rates has not been published.   Pulsed xenon UV technology, which emits light across the entire germicidal spectrum (200-300nm) including 253.7nm has been proven to reduce c-diff rates in published, peer-reviewed outcome studies including 50+ percent reductions.   Will the agency consider pulsed xenon UV?   LSCVAMC will evaluate your bid according to the specifications within solicitation # VA250-17-Q-0237. 6- If the government s objective is C-diff prevention at the Louis Stokes VAMC, shouldn t a salient characteristic be reducing unit and/or facility C-diff rates?   If so, what will the government use to evaluate this objective?   An evidence-based decision criteria would suggest C-diff outcome studies published in peer-reviewed journals showing reductions in unit and/or facility wide c-diff infection rates. LSCVAMC routinely monitors efficacy as part of our comprehensive Infection Prevention and Control program and our team will continue evaluation the efficacy of our efforts.   LSCVAMC will evaluate your bid according to the specifications within solicitation # VA250-17-Q-0237. 7- The specific location of pathogens within a room including c-diff is unknown.   Will a disinfection solution that disinfects all high touch surfaces be considered, if it does not have adjustable arms?   The agency s requirement appears to be the ability to treat hard to reach surfaces.   This can be accomplished by a system without adjustable arms.   The VA should consider other alternatives that meet its needs other than adjustable arms.   UVC sterilization is not intended to be a stand-alone system and will be used with other disinfection procedures and is part of a comprehensive Infection Prevention and Control program. LSCVAMC will evaluate your bid according to the specifications within solicitation # VA250-17-Q-0237. 8- The specific location of pathogens within a room including c-diff is unknown.   Will a UV disinfection solution that disinfects all high touch surfaces be considered, if it does not specifically treat surfaces at 7 feet?   Peer reviewed published studies on pulsed xenon UV disinfection focused on disinfecting high touch surfaces have shown significant reductions in unit and facility wide C-diff rates. UVC sterilization is not intended to be a stand-alone system and will be used with other disinfection procedures and is part of a comprehensive Infection Prevention and Control program.  LSCVAMC will evaluate your bid according to the specifications within solicitation # VA250-17-Q-0237. 9- What is the evaluation criteria of effectively treat surfaces ? What is the time and distance of the treatment time?   What is the specific pathogen being evaluated (C-diff, VRE, MRSA, Ebola, Anthrax)?   LSCVAMC will evaluate your bid according to the specifications within solicitation # VA250-17-Q-0237. 10- If a product generates ozone, but meets all safety standards will it be considered? If not, please explain the requirement for no ozone generation. LSCVAMC will evaluate your bid according to the specifications within solicitation # VA250-17-Q-0237. 11- Will burn-risks be considered? LSCVAMC will evaluate your bid according to the specifications within solicitation # VA250-17-Q-0237. 12- Will the material damage associated with continuous mercury (253.7nm) UVC devices be considered? LSCVAMC will evaluate your bid according to the specifications within solicitation # VA250-17-Q-0237.
 

Web Link

FBO.gov Permalink
(https://www.fbo.gov/spg/VA/BreVAMC/VAMCCO80220/VA25017Q0237/listing.html)
 

Document(s)

Attachment
 

File Name: VA250-17-Q-0237 VA250-17-Q-0237_4.docx (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=3386535&FileName=VA250-17-Q-0237-003.docx)

Link: https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=3386535&FileName=VA250-17-Q-0237-003.docx

 

Note: If links are broken, refer to Point of Contact above or contact the FBO Help Desk at 877-472-3779.
 

Place of Performance

Address: Department of Veterans Affairs;Louis Stokes Cleveland VA Medical Center;10701 East Boulevard;Cleveland, OH

Zip Code: 44106-1702
 

Record

SN04458209-W 20170405/170403235630-591f5754a74208a6bb69b514846f4b8f (fbodaily.com)
 

Source

FedBizOpps Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |